Life Science Leader’s October 2019 issue featured Laura Indolfi, CEO and cofounder of PanTher Therapeutics, in an article titled “Program Winners Look Back On Year Of Change.” Her company, which makes minimally invasive implantable devices that deliver direct, localized, and sustained cancer therapy to solid tumors, had won the first Massachusetts Next Generation Initiative (MassNextGen), a competitive program to support women entrepreneurs in early-stage life sciences companies. In June of this year, PanTher closed an oversubscribed $5.4M Series A, which sets the stage for the company’s first clinical trial.
Lauren Indolfi was awarded in 2018, the inaugural year that MassNextGen was launched. The program identifies promising women-led life sciences companies and provides critical funding and access to a robust panel of executive coaches to ensure that they have important resources to succeed.